The Investigational Drug Service (IDS), a research pharmacy operation at the University of Miami, supports clinical research trials, compassionate, and expanded-access drug use protocols. The IDS assists investigators at the Sylvester Comprehensive Cancer Center and the University of Miami Health System, in conducting investigator-initiated studies as well as industry- and federally funded drug studies.
Services
The IDS offers a wide range of services related to the use of investigational medications in clinical trials.
Our pharmacists and pharmacy technicians coordinate pharmacy involvement in investigational/clinical medication studies approved by the Institutional Review Board (IRB).
Our staff members perform medication acquisition, inventory management, investigational medication distribution, accountability, and on-site destruction.
At IDS, we handle and dispense investigational medication supplies in accordance with applicable legal, institutional, professional, and sponsor requirements.
Review our list of services and rates.
Trials
We currently manage over 450 open trials, ranging from phase 1 to phase 3. These include industry-sponsored, cooperative group, and investigator-initiated trials.
To learn more or request a budget for an upcoming study, email IDSresearch@med.miami.edu. With your request, please include a copy of your current protocol and pharmacy manual, if available.
Location
Sylvester Comprehensive Cancer Center Building
Room C120
1475 NW 12th Avenue
Miami, FL 33136
Contact Us
Phone: 305-243-5185
Fax: 305-243-1169
Email: IDSResearch@med.miami.edu
